S&P Futures
5,904.75 -1.25 (-0.02%) Dow Futures
43,559.00 +41.00 (+0.09%) Nasdaq Futures
20,450.25 -33.25 (-0.16%) Russell 2000 Futures
2,293.20 +2.00 (+0.09%) Crude Oil
69.82 +0.60 (+0.87%) Gold
2,743.90 +13.90 (+0.51%)
Cybin Inc. (CYBN.NE)
- Business Wire
Cybin to Participate in Water Tower Research Fireside Chat on October 8, 2024
TORONTO, October 03, 2024--Cybin Inc. (NYSE American:CYBN) (Cboe CA:CYBN) ("Cybin" or the "Company"), a clinical-stage breakthrough neuropsychiatry company committed to revolutionizing mental healthcare by developing new and innovative next-generation treatment options, is pleased to announce that Doug Drysdale, Cybin’s Chief Executive Officer, will participate in the Water Tower Research Fireside Chat Series taking place on Tuesday, October 8, 2024, at 3:00 p.m. ET.
- Business Wire
Cybin Expands Clinical Team to Support CYB003 Phase 3 Program
TORONTO, October 01, 2024--Cybin Inc. (NYSE American:CYBN) (Cboe CA:CYBN) ("Cybin" or the "Company"), a clinical-stage breakthrough neuropsychiatry company committed to revolutionizing mental healthcare by developing new and innovative next-generation treatment options, today announced the appointment of senior clinical team leaders, Dr. Mirza Rahman as Senior Vice President, Patient Safety & Pharmacovigilance and Dr. Marcelo Gutierrez, Vice President, Clinical Pharmacology, as well as the expan
